-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
July 19, 2013 - index, such as vancomycin and the aminoglycosides, the risk of toxicities is often a
dose-limiting factor … Inadequate antimicrobial treatment of infections: a
risk factor for hospital mortality among critically
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
August 24, 2011 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 24, 2011
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Nitrous Oxide for the Management of Labor Pain
Protocol Posting Date: May 11, 2011
Amendment Date(s) if applicable: Au…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
July 28, 2010 - Evidence-based Practice Center Technical Brief Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: July 28, 2010
1
Evidence-based Practice Center Technical Brief Protocol
Project Title: Technical Brief - Multidisciplinary Pain Programs for Chronic
Non-Cancer Pain
I. Background an…
-
effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
January 01, 2013 - In epidemiology, the term exposure can be broadly applied to any factor that may be associated with an
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
January 01, 2014 - Symptom
duration was identified as an important factor to consider; therefore an additional
subquestion
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
May 24, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 24, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Effectiveness of Screening and Treatment of C. difficile Infections
I. Background and Objectives for the Systematic Review
Clostr…
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - therapies such as monoclonal antibodies (infliximab, adalimumab,
tocilizumab) and tumor necrosis factor … in chronic
inflammatory diseases, such as antibody production by B cells, production of rheumatic factor … with moderate to severe, active RA who had an
inadequate response to at least one tumor necrosis factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - Effective Health Care
Topic Number(s): 0059
Document Completion Date: 6-2-09
1
Results of Topic Selection Process & Next Steps
Bone marrow transplants (BMT) in children will go forward for refinement as a comparative
effectiveness or effectiveness review. The scope of this topic, including po…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - We refer to these as multivariate risk factor analyses. … Effect of methotrexate, anti-tumor necrosis
factor alpha, and rituximab on the immune response to influenza
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - Evidence-based Practice Center Systematic Review Protocol
Page 1 of 25
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Hepatitis C Treatment Adherence
Interventions
I. Background and Objectives for the Systematic Review
Hepatitis C virus (HCV) infe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
September 01, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Multidisciplinary Pain Programs for Chronic Noncancer Pain
Draft review available for public com…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
March 31, 2010 - 1
Comparative Effectiveness Review
Number 115
Childhood Obesity Prevention Programs:
Comparative Effectiveness Review
and Meta-Analysis
Executive Summary
Background
The epidemic of childhood obesity
is threatening America’s children.1-3
Overweight children and adolescents
are at greater risk for health pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
September 20, 2017 - Noninvasive, Nonpharmacological Treatment for Chronic Pain
Evidence-based Practice Center Systematic Review Protocol
Project Title: Noninvasive, Nonpharmacological Treatment for Chronic Pain
Initial publication date if ap…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - Noninvasive Testing for Coronary Artery Disease
Evidence-based Practice Center Systematic Review Protocol
Project Title: Noninvasive Testing for Coronary Artery D…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - Pregnancy as a risk factor for restless legs syndrome.
Sleep medicine. 2004;5(3):305–308.
7. … Transient RLS during pregnancy is a risk factor for the
chronic idiopathic form.
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - therapies such as monoclonal antibodies (e.g., infliximab,
adalimumab, tocilizumab) and tumor necrosis factor … in chronic inflammatory
diseases, such as antibody production by B cells, production of rheumatic factor … with moderate to severe, active RA who had an
inadequate response to at least one tumor necrosis factor
-
effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
October 01, 2007 - ORIGINAL ARTICLE
Emerging Methods in Comparative Effectiveness
and Safety
Symposium Overview and Summary
Kathleen N. Lohr, PhD
Background: Interest in new methods for comparative effective-
ness, drug and patient safety, and related studies is burgeoning. The
advent of Medicare Part D for outpatient prescription dr…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
January 01, 2014 - non-native collagen from a
dressing to a recalcitrant wound may attract the excess MMPs allowing for growth factor … Currently, Becaplermin is the only FDA approved topical growth factor wound treatment
available in … given
Purpose:
Pilot Study to Evaluate the Safety and
Tolerability of Human Fibroblast
Growth Factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
October 25, 2011 - specific
audiences.
2 Introduction I think it should clarify that age is also an
important risk factor … The best study looking at OSA as a risk factor for
perioperative complications is for knee and hip … It is a complicating factor, but our expert and the TEP did
not think that changing definitions of OSA … Chest 2003) describing the difference
between efficacy and effectiveness, a critical
factor that is
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - Effective Health Care
Topic Number(s): 0041
Document Completion Date: 6-2-09
1
Results of Topic Selection Process & Next Steps
Clostridium difficile-associated disease (CDAD) will go forward for refinement as a comparative
effectiveness or effectiveness review. The scope of this topic, includi…